InvestorsHub Logo
Followers 5
Posts 2466
Boards Moderated 0
Alias Born 08/16/2016

Re: None

Thursday, 06/14/2018 1:36:33 PM

Thursday, June 14, 2018 1:36:33 PM

Post# of 3203
Some would save average down here. Others would say, never throw good money after bad...

It's a shame I read an article from a female reporter a year ago, that ACAD could soon be a buy out target, so it's too bad I took that to heart and bought in (going against my gut.)

It's also a shame that CNN wrote and inaccurate hit piece about Nuplazid, which caused the share price to drop 50%.

Biotech/pharmaceutical investments have always been a dangerous risk, but I think even much more now, in part due to the increase in technology, which obsoletes some drugs, which could happen here with Nuplazid.

Going back to fake new CNN, the problem is that some investors and some doctors believed the article and won't invest, or won't prescribe as much. The main problem with fake news, is once it's a headline, people ten to believe it based on emotion and don't dig any deeper. Also, if CNN posted a retraction, it would be on page 100 and few would ever read it.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ACAD News